Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians

被引：31

作者：

Alffenaar, Jan-Willem C. ^{[1
]}

Tiberi, Simon ^{[3
]}

Verbeeck, Roger K. ^{[4
]}

Heysell, Scott K. ^{[5
]}

Grobusch, Martin P. ^{[2
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 AB Groningen, Netherlands

[2] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Amsterdam, Netherlands

[3] Barts Hlth NHS Trust, Div Infect, London, England

[4] Univ Namibia, Sch Pharm, Windhoek, Namibia

[5] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2017年 / 64卷 / 01期

关键词：

GENOTYPE;

D O I：

10.1093/cid/ciw677

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：104 / +

页数：2

共 10 条

[1] NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy [J].

Azuma, Junichi ;

Ohno, Masako ;

Kubota, Ryuji ;

Yokota, Soichiro ;

Nagai, Takayuki ;

Tsuyuguchi, Kazunari ;

Okuda, Yasuhisa ;

Takashima, Tetsuya ;

Kamimura, Sayaka ;

Fujio, Yasushi ;

Kawase, Ichiro .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) :1091-1101

[2] The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid [J].

Donald, PR ;

Sirgel, FA ;

Venter, A ;

Parkin, DP ;

Seifart, HI ;

van de Wal, BW ;

Werely, C ;

van Helden, PD ;

Maritz, JS .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1425-1430

[3] Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics [J].

Ghimire, Samiksha ;

Bolhuis, Mathieu S. ;

Sturkenboom, Marieke G. G. ;

Akkerman, Onno W. ;

de Lange, Wiel C. M. ;

van der Werf, Tjip S. ;

Alffenaar, Jan-Willem C. .

EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (06) :1867-1869

[4] Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs [J].

Heysell, Scott K. ;

Pholwat, Suporn ;

Mpagama, Stellah G. ;

Pazia, Saumu J. ;

Kumburu, Happy ;

Ndusilo, Norah ;

Gratz, Jean ;

Houpt, Eric R. ;

Kibiki, Gibson S. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) :7104-7108

[5] Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement [J].

Lange, Christoph ;

Abubakar, Ibrahim ;

Alffenaar, Jan-Willem C. ;

Bothamley, Graham ;

Caminero, Jose A. ;

Carvalho, Anna Cristina C. ;

Chang, Kwok-Chiu ;

Codecasa, Luigi ;

Correia, Ana ;

Crudu, Valeriu ;

Davies, Peter ;

Dedicoat, Martin ;

Drobniewski, Francis ;

Duarte, Raquel ;

Ehlers, Cordula ;

Erkens, Connie ;

Goletti, Delia ;

Guenther, Gunar ;

Ibraim, Elmira ;

Kampmann, Beate ;

Kuksa, Liga ;

de lange, Wiel ;

van Leth, Frank ;

van Lunzen, Jan ;

Matteelli, Alberto ;

Menzies, Dick ;

Monedero, Ignacio ;

Richter, Elvira ;

Ruesch-Gerdes, Sabine ;

Sandgren, Andreas ;

Scardigli, Anna ;

Skrahina, Alena ;

Tortoli, Enrico ;

Volchenkov, Grigory ;

Wagner, Dirk ;

van der Werf, Marieke J. ;

Williams, Bhanu ;

Yew, Wing-Wai ;

Zellweger, Jean-Pierre ;

Cirillo, Daniela Maria .

EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (01) :23-63

[6]

Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376

[7] Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes [J].

Pasipanodya, Jotam G. ;

McIlleron, Helen ;

Burger, Andre ;

Wash, Peter A. ;

Smith, Peter ;

Gumbo, Tawanda .

JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09) :1464-1473

[8] End TB with precision treatment! [J].

van der Burgt, Evelien P. M. ;

Sturkenboom, Marieke G. G. ;

Bolhuis, Mathieu S. ;

Akkerman, Onno W. ;

Kosterink, Jos G. W. ;

de Lange, Wiel C. M. ;

Cobelens, Frank G. J. ;

van der Werf, Tjip S. ;

Alffenaar, Jan-Willem C. .

EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) :680-682

[9]

Vu DH, 2011, CURR PHARM DESIGN, V17, P2931, DOI 10.2174/138161211797470174

[10] Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis [J].

Zuur, Marlanka A. ;

Bolhuis, Mathieu S. ;

Anthony, Richard ;

den Hertog, Alice ;

van der Laan, Tridia ;

Wilffert, Bob ;

de Lange, Wiel ;

van Soolingen, Dick ;

Alffenaar, Jan-Willem C. .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (05) :509-521

← 1 →